RANI director purchases 2,083,334 shares, adds 2,083,334 warrants
Rhea-AI Filing Summary
Rani Therapeutics (RANI) reported insider activity: Director and 10% owner Mir A. Imran purchased 2,083,334 shares of Class A common stock at $0.605 on 10/23/2025 in a PIPE offering. He also acquired warrants to purchase 2,083,334 Class A shares with a $0.48 exercise price, which are exercisable upon stockholder approval and carry a five-year term from the date of such approval.
Following the transactions, he beneficially owns 2,083,334 Class A shares directly. Indirect holdings are reported as 74,139 Class A shares and 22,660,053 Class B shares through affiliated entities, subject to stated pecuniary interest disclaimers.
Positive
- None.
Negative
- None.
Insights
Neutral: Insider bought shares in a PIPE and received conditional warrants.
The filing shows Mir A. Imran bought $0.605 per share for 2,083,334 Class A shares on 10/23/2025 and acquired warrants for 2,083,334 Class A shares with a $0.48 exercise price. The warrants are exercisable upon stockholder approval and run five years from that approval date.
This indicates insider participation in a PIPE, with additional potential share issuance tied to the warrants if approval is obtained. Actual impact depends on the approval outcome and any subsequent exercises.
Key details to note are the purchase and exercise prices, the 10/23/2025 transaction date, and the approval condition governing exercisability; timing beyond these disclosures is not provided here.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrant to Purchase Class A Common Stock | 2,083,334 | $0.00 | -- |
| Purchase | Class A Common Stock | 2,083,334 | $0.605 | $1.26M |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
Footnotes (1)
- The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The warrants shall be exercisable upon stockholder approval and have a term of exercise equal to five years from the date of such stockholder approval.
